The pharmaceutical entrepreneur facing US charges of securities fraud said he had been the target of authorities for his drug-price hikes and over-the-top public persona.

Martin Shkreli, the former hedge fund manager vilified for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, has been arrested on securities fraud charges unrelated to the furore.